Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HESTER BIOSCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 HESTER BIOSCIENCES   MYLAN
EQUITY SHARE DATA
    HESTER BIOSCIENCES
Mar-23
MYLAN
Dec-18
HESTER BIOSCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs2,8523,969-   
Low Rs1,4162,185-   
Sales per share (Unadj.) Rs312.71,826.5-  
Earnings per share (Unadj.) Rs32.949.6-  
Cash flow per share (Unadj.) Rs57.3391.6-  
Dividends per share (Unadj.) Rs8.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs328.71,975.9-  
Shares outstanding (eoy) m8.51514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.81.7 404.9%   
Avg P/E ratio x64.762.0 104.4%  
P/CF ratio (eoy) x37.37.9 474.0%  
Price / Book Value ratio x6.51.6 416.7%  
Dividend payout %24.30-   
Avg Mkt Cap Rs m18,1521,583,163 1.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m5600-   
Avg. sales/employee Rs Th026,849.2-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0729.1-  
INCOME DATA
Net Sales Rs m2,661939,722 0.3%  
Other income Rs m1540-   
Total revenues Rs m2,814939,722 0.3%   
Gross profit Rs m548243,165 0.2%  
Depreciation Rs m207175,953 0.1%   
Interest Rs m9345,197 0.2%   
Profit before tax Rs m40222,015 1.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m121-3,502 -3.5%   
Profit after tax Rs m28025,517 1.1%  
Gross profit margin %20.625.9 79.6%  
Effective tax rate %30.2-15.9 -189.7%   
Net profit margin %10.52.7 388.0%  
BALANCE SHEET DATA
Current assets Rs m2,276524,740 0.4%   
Current liabilities Rs m1,487382,593 0.4%   
Net working cap to sales %29.715.1 196.0%  
Current ratio x1.51.4 111.6%  
Inventory Days Days4784 56.5%  
Debtors Days Days10993 117.1%  
Net fixed assets Rs m4,424182,291 2.4%   
Share capital Rs m85500 17.0%   
"Free" reserves Rs m2,7120-   
Net worth Rs m2,7971,016,607 0.3%   
Long term debt Rs m1,8491,097,246 0.2%   
Total assets Rs m6,7002,726,936 0.2%  
Interest coverage x5.31.5 357.0%   
Debt to equity ratio x0.71.1 61.2%  
Sales to assets ratio x0.40.3 115.3%   
Return on assets %5.62.6 215.0%  
Return on equity %10.02.5 399.3%  
Return on capital %10.63.2 334.9%  
Exports to sales %11.60-   
Imports to sales %00-   
Net fx Rs m2700-   
CASH FLOW
From Operations Rs m236195,274 0.1%  
From Investments Rs m-770-100,935 0.8%  
From Financial Activity Rs m418-90,970 -0.5%  
Net Cashflow Rs m-1161,618 -7.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.39 Rs / USD

Compare HESTER BIOSCIENCES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare HESTER BIOSCIENCES With: ZOTA HEALTH CARE  SANDU PHARMA  PARNAX LAB  TTK HEALTHCARE  AURO LAB.  



Today's Market

Sensex Today Trades Higher | Nifty Nears 22,700 | Trent Jumps 6%, Tata Chemicals Drops 3% Sensex Today Trades Higher | Nifty Nears 22,700 | Trent Jumps 6%, Tata Chemicals Drops 3%(10:30 am)

Asian stocks inched higher on Tuesday as investors awaited a slew of economic data, corporate earnings and the U.S. Federal Reserve's policy meeting.